Almac IRT solution designed to speed startup

By Jenni Spinner contact

- Last updated on GMT

(NanoStockk/iStock via Getty Images Plus)
(NanoStockk/iStock via Getty Images Plus)

Related tags: Almac, Clinical trials, COVID-19, Coronavirus, Data management

The company’s Simplify technology is designed to help sponsors and CROs reduce the time required to launch a clinical trial.

Almac Clinical technologies has launched Simplify, an interactive response technology (IRT) offering designed to let sponsors and contract research organizations launch trials more quickly. It enables users to conduct patient randomization, site and drug supply management, reportedly in much less time than traditional solutions.

Matt Cocking, Almac’s director of marketing, told Outsourcing-Pharma that Simplify improves upon previous IRT solutions by offering a higher degree of flexibility, enabling the product to be deployed more quickly and used more nimbly.

From the onset, the goal was to provide a high-quality, rapidly deployed IRT that can accommodate a long list of study permutations and protocol amendments at any time​,” Cocking explained. “Our IRT design consultants will evaluate your study objectives and ensure we’re providing the right solution.​”

The company analyzed more than 3,000 clinical trials supported with other Almac IRT solutions to pinpoint the most commonly requested and critical IRT functions. Additionally, Cocking told us, the company drew upon input from client and industry professionals.

Our product strategy committee really took note of the recurring theme that I mentioned previously: the frustration trial sponsors felt when they need a straightforward approach to patient randomization and trial supply management without the need for an extensively customized system, and couldn’t find exactly what they’re looking for. That was our starting point​,” he said.

Valarie Higgins, Almac president and managing director, said Simplify offers the flexibility necessary to enable users to scale the solution whenever the needs of a trial warrant.

Unplanned, or unexpected, protocol changes that require custom solutions can be swiftly implemented without requiring a major redesign, and are guided by our expert team of biostatistical, integration, design and support consultant​s,” she said.

Simplify is built upon Almac’s IXRS 3 customizable IRT platform. IXRS 3 was chosen as the foundation for Simplify, Cocking said, because of its robust architecture and extensive capabilities.

The end result is a high-quality IRT solution that can accommodate a vast array of protocol designs, yet doesn’t require trial sponsors and CROs to spend so much time in meetings with their suppliers​,” he said.

Cocking related an example of a customer who wanted to launch a COVID-19 trial and get the first patient in within 14 days.

We identified Simplify as the right approach and walked them through the capabilities. The next morning, we were given the green light, and within seven business days were ready to hand over the finished product to that sponsor​,” he said.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more